Sphera Funds Management Ltd. Selecta Biosciences Inc Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.62 - $0.85 $450,780 - $618,006	-727,066 Reduced 96.67%	25,071 $21,000
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $1.31 Million - $1.58 Million	-1,286,363 Reduced 63.1%	752,137 $797,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.4 $297,960 - $401,100	-286,500 Reduced 12.32%	2,038,500 $2.28 Million
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $2.67 Million - $4.39 Million	2,325,000 New	2,325,000 $3.23 Million
Q1 2018 May 10, 2018	SELL	$8.49 - $11.82 $1.94 Million - $2.7 Million	-228,534 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$15.22 - $20.03 $3.48 Million - $4.58 Million	228,534	228,534 $4.17 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.